Who will take vaccine with question marks on its reliability: Manish Tewari

Congress leader Manish Tewari said that the Bharatiya Janata Party (BJP) government has "politically misused" the Covid-19 pandemic and raised question marks on the reliability of the vaccine

Manish Tewari
File photo of Manish Tewari
ANI Politics
2 min read Last Updated : Jan 06 2021 | 7:14 AM IST

Congress leader Manish Tewari on Tuesday said that the Bharatiya Janata Party (BJP) government has "politically misused" the COVID-19 pandemic and raised question marks on the reliability of the vaccine.

"The BJP government has politically misused the COVID-19 pandemic in its entirety. The controversy over the vaccine is its latest manifestation. Who is going to get himself vaccinated with a vaccine that has question marks on its reliability," Tewari said.

"The BJP govt has done a great disservice to that company which must have invested crores of rupees in research and development. In their quest to prove their 'Atmanirbhar Bharat' they have licensed a vaccine whose phase III trials are not complete," he added.

Earlier on January 2, Akhilesh Yadav had said that he will not get vaccinated against coronavirus for now as the "BJP government cannot be trusted".

Meanwhile, Serum Institute of India and Bharat Biotech jointly communicated their pledge on Tuesday for the smooth rollout of COVID-19 vaccines to India and the world.

"Mr. Adar Poonawala and Dr. Krishna Ella, jointly on behalf of the two companies, today communicated their combined intent to develop, manufacture and supply the COVID-19 vaccines for India and globally," read a joint statement from SII and Bharat Biotech.

Adar Poonawala is Chief Executive Officer of SII. Dr. Krishna Ella is Chairman and Managing Director of Bharat Biotech.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusManish TewariCongressBharatiya Janata PartyCoronavirus Vaccineindian governmentindian politics

First Published: Jan 06 2021 | 7:08 AM IST

Next Story